P. L. Ornstein

发表

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

P. Ornstein, D. Schoepp, A. Kingston, 1998, Neuropharmacology.

Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects

D. McKinzie, G. Gilmour, J. Witkin, 2017, Pharmacology Biochemistry and Behavior.

Comparative Effects of LY3020371, a Potent and Selective mGlu2/3 Receptor Antagonist, and Ketamine, a Non-Competitive NMDA Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists for the Treatment of Depression

V. Tolstikov, S. Mitchell, G. Gilmour, 2017 .

A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists

D. Manallack, N. Young, D. Lodge, 1988, British journal of pharmacology.

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.

K. Perry, P. Ornstein, R. Fuller, 1991, European journal of pharmacology.

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity

Z. Bortolotto, P. Ornstein, G. Collingridge, 1998, Neuropharmacology.

The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus

G. Collingridge, P. Ornstein, D. Bleakman, 1998, Neuropharmacology.

Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.

P. Ornstein, M. O'Neill, D. Schoepp, 2000, The Journal of pharmacology and experimental therapeutics.

Neuroprotectant effects of LY 274614, a structurally novel systemically active competitive NMDA receptor antagonist

P. Ornstein, D. Schoepp, C. Salhoff, 2005, Journal of Neural Transmission / General Section JNT.

CGS-19755 and MK-801 selectively prevent rat striatal cholinergic and gabaergic neuronal degeneration induced by N-methyl-D-aspartate and ibotenate in vivo

P. Ornstein, D. Schoepp, C. Salhoff, 2005, Journal of Neural Transmission / General Section JNT.

[3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.

P. Ornstein, D. Schoepp, W. J. Wheeler, 2001, The Journal of pharmacology and experimental therapeutics.

Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisdoquinoline-3 carboxylic-acid.

B. Ballyk, P. Ornstein, D. Schoepp, 1996, Molecular pharmacology.